SCHEMBL361263

SCHEMBL361263

O=C(OC1CC2CCN1CC2)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
CHRNA7 P36544 4/20 0.50
HTR3E A5X5Y0 1/20 0.50
HTR3B O95264 1/20 0.50
HTR3A P46098 1/20 0.50
HTR3D Q70Z44 1/20 0.50
HTR3C Q8WXA8 1/20 0.50
SLC18A3 Q16572 1/20 0.50
CHRM2 P08172 2/20 0.46
CHRM4 P08173 2/20 0.46
CHRM1 P11229 2/20 0.46
CHRM3 P20309 2/20 0.46
APOBEC3A P31941 1/20 0.46
APOBEC3G Q9HC16 1/20 0.46
SCN1A P35498 1/20 0.44
SCN2A Q99250 1/20 0.44
SCN3A Q9NY46 1/20 0.44
CARM1 Q86X55 1/20 0.44
PRMT6 Q96LA8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16795980 1.00 MEN1 (0.51) MEN1KMT2ACHRNA7HTR3EHTR3B
SCHEMBL7206193 0.76 CHRM3 (0.57) CHRM2CHRM4CHRM1CHRM3
SCHEMBL827869 0.76 CHRM3 (0.57) CHRM2CHRM4CHRM1CHRM3
SCHEMBL3980371 0.76 CHRM3 (0.57) CHRM2CHRM4CHRM1CHRM3
SCHEMBL27751858 0.74 MEN1 (0.68) MEN1KMT2ACHRNA7HTR3EHTR3B
SCHEMBL7525984 0.74 CHRM3 (0.45) CHRM2CHRM4CHRM1CHRM3
SCHEMBL6828946 0.73 MEN1 (0.54) MEN1KMT2ACHRNA7HTR3EHTR3B
SCHEMBL10813833 0.73 CHRM3 (0.42) CHRM2CHRM4CHRM1CHRM3
SCHEMBL27751859 0.72 MEN1 (0.64) MEN1KMT2ACHRNA7HTR3EHTR3B
SCHEMBL5857109 0.72 CHRM3 (0.38) CHRM2CHRM4CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015087291-A1 3-CARBOXY-4-(R)-PHENYLPYRROLYDINE-2-ONE SALT AND ITS USE JSC OLAINFARM (LV) 2015-06-18 WO claimed
US-20240103013-A1 PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF VIB VZW (BE) 2024-03-28 US disclosed
EP-4273549-A1 PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF VIB VZW (BE) 2023-11-08 EP disclosed
EP-3557254-B1 PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF VIB VZW (BE) 2021-12-15 EP disclosed
EP-3557255-B1 PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF VIB VZW (BE) 2021-11-17 EP disclosed
US-11162954-B2 Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof VIB VZW (BE) 2021-11-02 US disclosed
US-11162953-B2 Protein binding domains stabilizing functional conformational states of GPCRS and uses thereof VIB VZW (BE) 2021-11-02 US disclosed
EP-2593792-B1 PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF VIB VZW (BE) 2019-11-13 EP disclosed
EP-3557256-A1 PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF VIB vzw (BE) 2019-10-23 EP disclosed
EP-3557255-A1 PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF VIB vzw (BE) 2019-10-23 EP disclosed
EP-0099303-B1 BENZOTHIOPYRANOPYRIDINONES AND THEIR SALTS, THEIR PREPARATION AND USE AS MEDICAMENTS, AND COMPOSITIONS CONTAINING THEM ROUSSEL-UCLAF (FR) 1987-08-19 EP disclosed
US-4567178-A ANTIULCER AGENTS DR. KARL THOMAE GMBH (DE) 1986-01-28 US disclosed
US-4550107-A Condensed diazepinones, their compositions and methods of use as pharmaceuticals DR. KARL THOMAE GMBH (DE) 1985-10-29 US disclosed
US-4518779-A 1,2,3,4-Tetrahydro-1-aminomethyl-4-phenyl isoquinolines PENNWALT CORPORATION (US) 1985-05-21 US disclosed
US-4517187-A 1,3,4,6,7-11b-Hexahydro-7-phenyl-2H-pyrazino[2,1-a]isoquinolines methods of preparation, and use as antidepressants PENNWALT CORPORATION (US) 1985-05-14 US disclosed
EP-0135125-A2 NMR imaging utilizing chemical shift reagents E.I. DU PONT DE NEMOURS AND COMPANY (US) 1985-03-27 EP disclosed
EP-0107825-A1 1,3,4,6,7,11b-Hexahydro-7-aryl-2H-pyrazino (2,1-alpha) isoquinolines useful as intermediates and pharmaceutical compounds and methods of preparation PENNWALT CORPORATION (US) 1984-05-09 EP disclosed
EP-0104604-A1 1,2,3,4-Tetrahydro-1-aminomethyl-4-phenyl isoquinolines and methods of preparation PENNWALT CORPORATION (US) 1984-04-04 EP disclosed
EP-0099303-A2 Benzothiopyranopyridinones and their salts, their preparation and use as medicaments, and compositions containing them ROUSSEL-UCLAF (FR) 1984-01-25 EP disclosed
US-4410527-A ANTIULCER AGENTS DR. KARL THOMAE GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1983-10-18 US disclosed